RxSight, Inc.
RXST- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- SEC CIK
- 0001111485
In the last 90 days, RxSight, Inc. insiders filed 0 open-market purchases and 4 sales; 151 institutions reported holding it in 13F filings for Q2 2026, worth $199.8M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in RxSight, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 128
- +13 vs. Q2 2023
- Shares held
- 25.7M
- +3.63M (+16.4%) vs. Q2 2023
- Total value
- $718.1M
- +$81.1M (+12.7%) vs. Q2 2023
- New holders
- 28
- 49 more added
- Sold out
- 15
- 32 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RXST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 151 | $199.8M |
| Q1 2026 | 164 | $235.2M |
| Q4 2025 | 164 | $381.8M |
| Q3 2025 | 160 | $298.8M |
| Q2 2025 | 174 | $481.2M |
| Q1 2025 | 192 | $924.1M |
| Q4 2024 | 212 | $1.21B |
| Q3 2024 | 214 | $1.68B |
| Q2 2024 | 228 | $1.98B |
| Q1 2024 | 197 | $1.58B |
| Q4 2023 | 169 | $1.17B |
| Q3 2023 | 128 | $718.1M |
| Q2 2023 | 115 | $637.0M |
| Q1 2023 | 74 | $264.4M |
| Q4 2022 | 58 | $121.6M |
| Q3 2022 | 53 | $109.3M |
| Q2 2022 | 49 | $131.0M |
| Q1 2022 | 45 | $108.3M |
| Q4 2021 | 40 | $75.0M |
| Q3 2021 | 39 | $100.3M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding RxSight, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 239,194 | $6.67M | 0.00% | +16,610+7.5% | Added |
| Allspring Global Investments Holdings, LLC | 243,346 | $6.79M | 0.01% | +176,451+263.8% | Added |
| No Street GP LP | 250,000 | $6.97M | 0.84% | +250,000 | New |
| Two Sigma Advisers, LP | 270,300 | $7.54M | 0.02% | +156,200+136.9% | Added |
| Polar Asset Management Partners Inc. | 291,600 | $8.13M | 0.20% | +99,000+51.4% | Added |
| Two Sigma Investments, LP | 310,866 | $8.67M | 0.02% | +34,744+12.6% | Added |
| Federated Hermes, Inc. | 312,591 | $8.72M | 0.02% | −2,823−0.9% | Reduced |
| Norges Bank | 325,500 | $9.08M | 0.00% | +140,000+75.5% | Added |
| Voloridge Investment Management, LLC | 356,643 | $9.95M | 0.05% | +174,488+95.8% | Added |
| Parkman Healthcare Partners LLC | 381,331 | $10.6M | 1.95% | −117,300−23.5% | Reduced |
| Nuveen Asset Management, LLC | 431,477 | $12.0M | 0.00% | +310,992+258.1% | Added |
| Atika Capital Management LLC | 509,352 | $14.2M | 2.02% | −4,648−0.9% | Reduced |
| Geode Capital Management, LLC | 518,139 | $14.5M | 0.00% | +66,320+14.7% | Added |
| T. Rowe Price Investment Management, Inc. | 540,688 | $15.1M | 0.01% | +540,688 | New |
| JPMorgan Chase & Co | 551,565 | $15.4M | 0.00% | +11,431+2.1% | Added |
| Driehaus Capital Management LLC | 593,958 | $16.6M | 0.22% | +121,363+25.7% | Added |
| Bank of America Corp | 633,194 | $17.7M | 0.00% | +478,527+309.4% | Added |
| Point72 Asset Management, L.P. | 655,945 | $18.3M | 0.06% | +83,502+14.6% | Added |
| Divisadero Street Capital Management, LP | 680,000 | $19.0M | 5.98% | +480,000+240.0% | Added |
| State Street Corp | 703,961 | $19.6M | 0.00% | +254,081+56.5% | Added |
| Next Century Growth Investors LLC | 747,827 | $20.9M | 2.27% | −85,558−10.3% | Reduced |
| Millennium Management LLC | 1,161,053 | $32.4M | 0.03% | −72,300−5.9% | Reduced |
| Morgan Stanley | 1,211,404 | $33.8M | 0.00% | −295,671−19.6% | Reduced |
| Vanguard Group Inc | 1,433,953 | $40.0M | 0.00% | +255,150+21.6% | Added |
| Lord, Abbett & Co. LLC | 1,628,320 | $45.4M | 0.17% | +197,099+13.8% | Added |
| BlackRock Inc. | 1,853,089 | $51.7M | 0.00% | +223,161+13.7% | Added |
| Artisan Partners Limited Partnership | 2,437,765 | $68.0M | 0.12% | +359,295+17.3% | Added |
| Ra Capital Management, L.P. | 3,052,796 | $85.1M | 1.68% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −71,680−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −46,044−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −38,900−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −30,491−100.0% | Sold out |
| Temasek Holdings (Private) Ltd | 0 | $0 | 0.00% | −21,694−100.0% | Sold out |
| Boston Partners | 0 | $0 | 0.00% | −20,436−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −17,544−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −15,679−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −15,270−100.0% | Sold out |
| Zacks Investment Management | 0 | $0 | 0.00% | −13,830−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −10,012−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −9,431−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −7,297−100.0% | Sold out |
| Counterpoint Mutual Funds LLC | 0 | $0 | 0.00% | −4,543−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −4,400−100.0% | Sold out |